474 related articles for article (PubMed ID: 23196467)
1. [Recent topics of chronic inflammatory demyelinating polyneuropathy].
Iijima M
Rinsho Shinkeigaku; 2012; 52(11):917-9. PubMed ID: 23196467
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and long-term characteristics of the subtypes of chronic inflammatory demyelinating polyneuropathy].
Shimizu F; Nemoto J; Takeshita Y; Maeda T; Koga M; Kanda T
Rinsho Shinkeigaku; 2022 Mar; 62(3):173-177. PubMed ID: 35228460
[TBL] [Abstract][Full Text] [Related]
3. Treatment Approaches for Atypical CIDP.
Menon D; Katzberg HD; Bril V
Front Neurol; 2021; 12():653734. PubMed ID: 33790853
[TBL] [Abstract][Full Text] [Related]
4. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
[TBL] [Abstract][Full Text] [Related]
5. Cranial nerve involvement in typical and atypical chronic inflammatory demyelinating polyneuropathies.
Shibuya K; Tsuneyama A; Misawa S; Suichi T; Suzuki Y; Kojima Y; Nakamura K; Kano H; Prado M; Kuwabara S
Eur J Neurol; 2020 Dec; 27(12):2658-2661. PubMed ID: 32876980
[TBL] [Abstract][Full Text] [Related]
6. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
Nobile-Orazio E
J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of Chronic Inflammatory Demyelinating Polyneuropathy: Insights into Classification and Therapeutic Strategy.
Koike H; Katsuno M
Neurol Ther; 2020 Dec; 9(2):213-227. PubMed ID: 32410146
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy.
Ikeda S; Koike H; Nishi R; Kawagashira Y; Iijima M; Katsuno M; Sobue G
J Neurol Neurosurg Psychiatry; 2019 Sep; 90(9):988-996. PubMed ID: 31227562
[TBL] [Abstract][Full Text] [Related]
9. Chronic Inflammatory Demyelinating Polyneuropathy.
Kuwabara S; Misawa S
Adv Exp Med Biol; 2019; 1190():333-343. PubMed ID: 31760654
[TBL] [Abstract][Full Text] [Related]
10. Clinical spectrum of chronic acquired demyelinating polyneuropathies.
Saperstein DS; Katz JS; Amato AA; Barohn RJ
Muscle Nerve; 2001 Mar; 24(3):311-24. PubMed ID: 11353415
[TBL] [Abstract][Full Text] [Related]
11. A review of the medical management of chronic inflammatory demyelinating polyradiculoneuropathy.
Léger JM
Expert Opin Pharmacother; 2005 Apr; 6(4):569-82. PubMed ID: 15934883
[TBL] [Abstract][Full Text] [Related]
12. Research criteria for defining patients with CIDP.
Sander HW; Latov N
Neurology; 2003 Apr; 60(8 Suppl 3):S8-15. PubMed ID: 12707417
[TBL] [Abstract][Full Text] [Related]
13. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
Larue S; Bombelli F; Viala K; Neil J; Maisonobe T; Bouche P; Musset L; Fournier E; Léger JM
Eur J Neurol; 2011 Jun; 18(6):899-905. PubMed ID: 21199182
[TBL] [Abstract][Full Text] [Related]
14. The distribution pattern of nerve enlargement in clinical subtypes of chronic inflammatory demyelinating polyneuropathy.
Niu J; Zhang L; Hu N; Cui L; Liu M
J Neuroimaging; 2024; 34(1):127-137. PubMed ID: 37823703
[TBL] [Abstract][Full Text] [Related]
15. [Cutting edge of diagnosis and treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) based on the EAN/PNS guideline 2021].
Kuwabara S
Rinsho Shinkeigaku; 2024 May; 64(5):321-325. PubMed ID: 38644208
[TBL] [Abstract][Full Text] [Related]
16. Acquired inflammatory demyelinating neuropathies.
Ensrud ER; Krivickas LS
Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
[TBL] [Abstract][Full Text] [Related]
17. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
18. Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypes.
Shimizu F; Sawai S; Sano Y; Beppu M; Misawa S; Nishihara H; Koga M; Kuwabara S; Kanda T
PLoS One; 2014; 9(8):e104205. PubMed ID: 25105500
[TBL] [Abstract][Full Text] [Related]
19. Increased IP-10 production by blood-nerve barrier in multifocal acquired demyelinating sensory and motor neuropathy and multifocal motor neuropathy.
Shimizu F; Oishi M; Sawai S; Beppu M; Misawa S; Matsui N; Miyashiro A; Maeda T; Takeshita Y; Nishihara H; Sano Y; Sato R; Kaji R; Kuwabara S; Kanda T
J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):444-450. PubMed ID: 30523038
[TBL] [Abstract][Full Text] [Related]
20. Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants.
De Lorenzo A; Liberatore G; Doneddu PE; Manganelli F; Cocito D; Briani C; Fazio R; Mazzeo A; Schenone A; Di Stefano V; Cosentino G; Marfia GA; Benedetti L; Carpo M; Filosto M; Antonini G; Clerici AM; Luigetti M; Matà S; Rosso T; Lucchetta M; Siciliano G; Lauria Pinter G; Cavaletti G; Inghilleri M; Cantisani T; Notturno F; Ricciardi D; Habetswallner F; Spina E; Peci E; Salvalaggio A; Falzone Y; Strano C; Gentile L; Vegezzi E; Mataluni G; Cotti Piccinelli S; Leonardi L; Romano A; Nobile-Orazio E;
Eur J Neurol; 2024 Apr; 31(4):e16190. PubMed ID: 38165011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
